JPRN-UMIN000007007已完成未知
A randomized controlled trial of Attention Bias Modification Treatment (ABMT) for highly anxious adults: A functional MRI investigation of the neural mechanisms of the ABMT - A randomized controlled trial of Attention Bias Modification Treatment (ABMT) for highly anxious adults
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 30years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Presence of significant psychiatric disorders determined by the Mini International Neuropsychiatric Interview 2) Presence of significant medical illnesses 3) History of traumatic brain injury 4) Patient of psychiatry 5) Psychotropic medication within the previous month 6) Over-intake of caffeine 7) Metal implants that interfere with the MRI safety 8) Pregnancy
研究者
相似试验
进行中（未招募）
不适用
A placebo-controlled, double-blind, randomised study to evaluate the efficacy and safety of TAK-475 100mg in subjects with type 2 diabetes currently treated with lipid-lowering therapy.Treatment of patients with primary dyslipidaemiaMedDRA version: 8Level: ptClassification code 10058108EUCTR2005-002316-24-DETakeda Europe R &D Centre Ltd400
进行中（未招募）
1 期
A placebo-controlled, double-blind, randomised study to evaluate the efficacy and safety of TAK-475 100mg in subjects with type 2 diabetes currently treated with lipid-lowering therapy.treatment of patients with primary dyslipidaemiaMedDRA version: 8Level: ptClassification code 10058108EUCTR2005-002316-24-SKTakeda Global R &D Centre (Europe)400
进行中（未招募）
不适用
A placebo-controlled, double-blind, randomised study to evaluate the efficacy and safety of TAK-475 100mg in subjects with type 2 diabetes currently treated with lipid-lowering therapy.treatment of patients with primary dyslipidaemiaMedDRA version: 8Level: ptClassification code 10058108EUCTR2005-002316-24-LVTakeda Europe R &D Centre Ltd400
进行中（未招募）
不适用
A study to see how effective and safe the drug Kappaproct is in patients with refractory ulcerative colitis when added to their standard care of treatmentChronic active treatment refractory ulcerative colitisMedDRA version: 16.1Level: PTClassification code 10009900Term: Colitis ulcerativeSystem Organ Class: 10017947 - Gastrointestinal disordersEUCTR2011-003130-14-CZInDex Pharmaceuticals AB120
进行中（未招募）
不适用
Clinical Trial to assess the efficacy and safety of KappaproctChronic active treatment refractory ulcerative colitisMedDRA version: 14.1Level: PTClassification code 10009900Term: Colitis ulcerativeSystem Organ Class: 10017947 - Gastrointestinal disordersEUCTR2011-003130-14-ITINDEX PHARMACEUTICALS132